Bulk drug intermediates are the drugs used as raw materials for the manufacturing of bulk drugs, or they can describe as material produced during the course of the synthesis of an API that needs to undergo further molecular change or processing before it eventually becomes an API. Drug intermediates are hygienically developed making use of very high-grade raw materials and they are generally used in the pharmaceutical and cosmetic sectors. Pharmaceutical firms use drugs intermediates for r & d purposes. Veterinary intermediates, pharmaceutical drug intermediates, and bulk drug intermediates are different kinds of drug intermediates. The international drug intermediate market is expected to expand at a very high rate owing to rising r & d activity around the world.
The market of drug intermediates is fragmented on the basis of kind of intermediate, end-user. On the basis of type of intermediate, the market is divided into two major types:
API intermediate: API or active pharmaceutical ingredient intermediates are the raw materials or raw drugs causing therapeutic action. They are the active ingredients which are afterwards converted into numerous forms such as capsules, tablets, suspensions etc. API serves as a drug itself.
Advanced intermediate: Advanced intermediates are more advanced types of drug intermediates.
Advanced intermediate drugs are generally used to carry out drug interaction activity which developed in new chemical products.
On the basis of end-user, the international drug intermediate market is fragmented into the Biotechnology industry, Pharmaceutical industry, and Chemical industry.
Drug intermediates are readily available in different forms like high-quality intermediates, moderate intermediates, and premium quality intermediates. The high, as well as premium quality drug intermediates, are used primarily for research purposes. There has been an ever-increasing worldwide demand for quality drug intermediates because of the fast-expanding biotechnology and life sciences sectors, in addition to rising adoption and increasing application in research fields. Pharmaceutical firms and biotechnology companies, together with research companies are focusing more on R&D in drug discovery and development.
The increasing competition in the Biotechnology and Pharmaceutical industry for the outsourcing of drug intermediates and the manufacturing of drug intermediates is predicted to boost the growth of the international drug intermediate market.
Sai Chemie Inc is one of the top manufacturers of pharmaceutical intermediates in India.